Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM32UOC)

Drug Name

EDP-938 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Respiratory syncytial virus infection	1C80	Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Respiratory syncytial virus protein N (RSV N)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
RSV-604	DMAJH75	Virus infection	1A24-1D9Z	Phase 2	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Respiratory syncytial virus protein N (RSV N)	TT25A0I	NCAP_HRSVA	Inhibitor	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04816721) A Study to Evaluate EDP 938 Regimens in Infants With RSV (RSVPEDs). U.S. National Institutes of Health.
2	EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model. PLoS Pathog. 2021 Mar 15;17(3):e1009428.
3	Mechanism of action for respiratory syncytial virus inhibitor RSV604. Antimicrob Agents Chemother. 2015 Feb;59(2):1080-7.